Skip to Content
Merck
All Photos(1)

Documents

528900

Sigma-Aldrich

2-Bromo-5-fluoroaniline

97%

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Linear Formula:
BrC6H3(F)NH2
CAS Number:
1003-99-2
Molecular Weight:
190.01
MDL number:
MFCD00070750
UNSPSC Code:
12352100
PubChem Substance ID:
24877625
NACRES:
NA.22

Assay

97%

mp

43-47 °C (lit.)

SMILES string

Nc1cc(F)ccc1Br

InChI

1S/C6H5BrFN/c7-5-2-1-4(8)3-6(5)9/h1-3H,9H2

InChI key

FWTXFEKVHSFTDQ-UHFFFAOYSA-N

Application

2-Bromo-5-fluoroaniline may be used to synthesize:
  • orthobromothiobenzanilide of 5-fluoronitrobenzothiazole
  • 2-bromo-5-fluorobenzo[14C]nitrile
  • [3-14C]-5-fluoro-1,3-dihydro-1-hydroxy-2,1-benzoxaborole
  • 2-bromo-5-fluoro-phenyl)-(2-methoxy-6-pentadecyl-benzyl)amine

Pictograms

Exclamation mark
GHS07

Signal Word

Warning

Hazard Statements

H315,H319,H335

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

Target Organs

Respiratory system

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

230.0 °F - closed cup

Flash Point(C)

110 °C - closed cup

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Synthesis of novel benzylamine analogues of Anacardic acid as potent antibacterial agents.
Dubey PK.
Der Pharma Chemica, 3(6), 500-512 (2011)
Synthesis of isotopically labelled [3-14C]-and [3, 3-2H2]-5-fluoro-1, 3-dihydro-1-hydroxy-2, 1-benzoxaborole (AN2690), a new antifungal agent for the potential treatment of onychomycosis.
Baker SJ, et al.
Journal of Labelled Compounds & Radiopharmaceuticals, 50(4), 245-250 (2007)
T D Bradshaw et al.
Current medicinal chemistry, 11(8), 1009-1021 (2004-04-14)
This review traces the development of a series of potent and selective antitumour benzothiazoles from the discovery of the initial lead compound, 2-(4-amino-3-methylphenyl)benzothiazole (DF 203) in 1995 to the identification of a clinical candidate, Phortress, scheduled to enter Phase 1

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service